全球细胞分离市场规模：按产品、按细胞类型、按细胞来源、按最终用户、按地区、范围和预测

细胞分离市场规模及预测

2023年细胞分离市场规模为98.2亿美元，预计到2031年将达到341.3亿美元，2024年至2031年复合年增长率为16.85%。细胞分离是指从组织或培养物等复杂组合中移除单一细胞或特定细胞群，同时维持其存活和功能的过程。此方法对于各种生物和医学研究应用至关重要，包括基于细胞的测定、再生医学和癌症研究。透过分离细胞，研究人员可以更精确地检查它们的特性、行为和相互作用，从而深入了解细胞活动、疾病原因和潜在的治疗方法。

此外，用于提取不同细胞类型的技术包括机械分离、酶消化、萤光激活细胞分选 (FACS) 和磁激活细胞分选 (MACS)。这些技术基于尺寸、密度、表面标记和其他独特属性等因素。

细胞分离市场动态

塑造细胞分离市场的主要市场动态

主要市场驱动因子

生物技术与生命科学的进展：

生物技术和生命科学领域的快速创新，包括自动化和高通量方法，显着改进了细胞分离程序。这些改进使得特定细胞类型的分离更有效率、准确且经济高效，进而推动市场成长。

对个人化医疗的需求不断增加：

对个人化医疗和标靶医学的日益重视需要分离特定的细胞类型进行研究和开发。因此，细胞分离对于阐明疾病原因、开发诊断方法和设计个人化疗法至关重要，也推动了细胞分离技术的市场引入。

慢性病和研究活动的增加：

癌症和糖尿病等慢性病的盛行率不断上升，增加了对这些疾病的研究需求。因此，细胞分离对于研究疾病的发病机制、发现新的治疗技术和药物至关重要。

增加对细胞疗法的投资：

这些疗法使用干细胞和 CAR T 细胞等分离细胞来治疗各种疾病。早期细胞药物的成功和治疗疑难杂症的前景吸引了大量投资，并支持细胞分离市场的扩张。

主要问题

技术/操作问题：

细胞分离过程非常精确，技术难度也很大。分离高纯度和高活力的细胞，特别是从复杂组织和特定细胞类型中分离，需要先进的技术和程序，限制了市场成长机会。此外，在保持品质和经济性的同时增加这些步骤的数量也是市场上的一个主要问题。

道德问题：

某些细胞分离应用，特别是那些使用人类胚胎干细胞或基因操作的应用，引起了细胞分离市场的伦理问题。这种道德问题提高了公众意识，降低了消费者的接受度，并影响了一些地方的监管法律，从而限制了研究工作和商业利用。

市场竞争与创新压力：

细胞分离市场竞争激烈，许多竞争对手竞相提供创新解决方案。跟上技术的快速进步并降低成本，同时满足不断变化的最终用户需求，需要大量投资，这对维持获利能力和市场地位构成了重大挑战。

主要趋势

自动化与高通量技术：

自动化细胞分离方法以提高通量、消除人为错误并提高重现性的趋势日益明显。能够以最少的人力同时处理多个样本的自动化方法和设备越来越受欢迎，进一步刺激了市场扩张。

干细胞研究与治疗的成长：

干细胞研究领域的扩展以及干细胞在治疗中的使用不断增加正在推动对高效细胞分离技术的需求。分离高品质干细胞已成为再生医学、组织工程和各种细胞疗法的关键，推动了维持细胞完整性和活性的温和高效分离技术的进步。

特定细胞分离的先进技术：

FACS 和 MACS 技术的进步提高了分离细胞的纯度和活力。基于微流体的细胞分离技术的发展也在不断发展，即使在异质样本中也能够精确识别特定细胞类型，这对于研究、治疗和诊断至关重要。

细胞分离市场的区域分析

细胞分离市场的详细区域分析

北美：

根据经过验证的市场研究，预计北美将在预测期内主导细胞分离市场。该地区在医疗保健和生物技术行业，特别是基于细胞的研究和製药领域进行了大量的财务投资。这些投资使得尖端细胞分离技术和服务的创造和商业化成为可能，从而推动市场成长。

北美是个人化医疗领域的先驱，主要依靠以细胞为基础的治疗和诊断。对干细胞治疗和免疫治疗等个人化治疗的需求，需要精确的细胞分离和分析，正在推动细胞分离技术市场的发展。

此外，北美的监管环境，特别是透过 FDA（美国食品药物管理局），促进了生物技术和製药领域的创新。细胞药物和产品的监管流程十分完善，能够快速批准并接受创新技术。这种有利的监管框架鼓励公司开发和传播新的细胞分离技术和产品。

欧洲

欧洲拥有完善的医疗保健体系，在医疗保健上花费大量资金，因此很容易获得细胞分离等最新的医疗技术。这种基础设施使持续的医学研究和创新疗法的开发成为可能，从而实现稳定的市场成长。

欧洲的人口老化和慢性疾病负担的增加需要尖端的诊断和治疗技术，包括基于细胞的药物。研究和临床应用中对精确细胞分离的需求正在推动市场扩张。

此外，欧盟 (EU) 为生物医学研究提供全面的监管框架和融资体系，并促进细胞分离技术的创新。例如，地平线欧洲鼓励研究合作，同时推动技术和扩大市场。

亚太地区：

预计亚太地区在预测期内将以最高的复合年增长率成长。由于政府当局增加的投资和支持，亚太地区的生技公司正在蓬勃发展。这种扩张创造了对研发、生物製药生产和临床诊断所必需的细胞分离技术的需求。

随着政府和私营部门对医院和研究机构的投资，该地区的医疗保健基础设施正在迅速扩张。这种扩张促进了尖端技术的使用，例如用于製药和诊断目的的细胞分离。

此外，亚太地区面临着癌症和糖尿病等慢性疾病日益沉重的负担，需要新的诊断和治疗方法。因此，细胞分离对于个人化医疗和客製化治疗的进一步应用至关重要，从而推动市场成长。

目录

第1章 全球细胞分离市场简介

• 市场概要
• 调查范围
• 前提条件

第2章 摘要整理

第3章 VERIFIED MARKET RESEARCH的调查手法

• 资料探勘
• 验证
• 一次采访
• 资料来源一览

第4章 全球细胞分离市场展望

• 概要
• 市场动态
  • 促进因素
  • 阻碍因素
  • 机会
• 波特的五力分析
• 价值链分析

第5章 细胞分离的全球市场:各产品

• 概要
• 消耗品
  • 试剂，套件，培养基，血清
  • 珠
  • 消耗品
• 设备
  • 离心机
  • 细胞分选仪
  • 磁激活细胞分离系统
  • 过滤系统

第6章 细胞分离的全球市场:细胞各类型

• 概要
• 人细胞
• 动物细胞

第7章 细胞分离的全球市场:细胞各来源

• 概要
• 骨髓
• 脂肪组织
• 脐带血/胚胎干细胞
• 其他的细胞酱汁(来源)

第8章 细胞分离的全球市场:各终端用户

• 概要
• 製药·生物科技企业
• 学术·研究机关
• 医院·诊断研究所
• 其他的终端用户

第9章 细胞分离的全球市场:各地区

• 概要
• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 全球其他地区
  • 南美
  • 中东·非洲

第10章 全球细胞分离市场:竞争情形

• 概要
• 各公司的市场排行榜
• 主要的发展策略

第11章 企业简介

• Thermo Fisher Scientific
• Miltenyi Biotec
• BD Biosciences
• Merck
• Eppendorf
• GE Healthcare
• Danaher Corporation
• PerkinElmer
• Agilent Technologies
• Bio-Rad Laboratories

第12章 附录

• 相关调查

Cell Isolation Market Size and Forecast

Cell Isolation Market size was valued at USD 9.82 Billion in 2023 and is projected to reach USD 34.13 Billion by 2031 , growing at a CAGR of 16.85% from 2024 to 2031. Cell isolation refers to the process of removing individual cells or specific cell populations from a complicated combination, such as tissues or cultures, while keeping them viable and functional. This method is essential for a variety of biological and medical research applications, including cell-based assays, regenerative medicine, and cancer research. By isolating cells, researchers can examine their properties, behavior, and interactions with greater precision, yielding insights into cellular activities, disease causes, and potential therapeutic approaches.

Additionally, the techniques used to extract different cell types are mechanical separation, enzymatic digestion, fluorescence-activated cell sorting (FACS), magnetic-activated cell sorting (MACS), and others. These techniques are based on factors like size, density, surface markers, or other unique characteristics.

Cell Isolation Market Dynamics

The key market dynamics that are shaping the Cell Isolation Market include:

Key Market Drivers

Advancements in Biotechnology and Life Sciences:

Rapid technical breakthroughs in biotechnology and life sciences, such as automation and high-throughput approaches, have greatly enhanced cell isolation procedures. These improvements enable more efficient, precise, and cost-effective isolation of certain cell types, resulting in market growth.

Growing Demand for Personalized Medicine:

The growing emphasis on personalized medicine and targeted medicines demands the separation of certain cell types for research and development. As a result, cell isolation becomes essential for understanding disease causes, generating diagnostics, designing personalized therapeutics, and also bolstering market adoption of cell isolation techniques.

Increase in Chronic Diseases and Research Activities:

The increasing prevalence of chronic diseases like cancer and diabetes is increasing the demand for research into these conditions. Thus, cell isolation serves essential for studying disease pathogenesis, leading to new therapy techniques and medication discoveries.

Growing Investments in Cell-based Therapies:

These therapies cure a variety of disorders by using isolated cells such as stem cells or CAR T cells. The success of early cell-based medicines, as well as their promise to treat difficult illnesses, have attracted significant investment, supporting the expansion of the Cell Isolation Market.

Key Challenges:

Technical and Operational Challenges:

Cell isolation procedures are very precise and technically difficult. Isolating cells with high purity and viability, especially from complex tissues or for specific cell types, necessitates advanced technology and procedures, limiting market growth opportunities. Also, increasing these processes while preserving quality and economy presents considerable problems in the market.

Ethical Concerns:

Certain cell isolation applications, particularly those that use human embryonic stem cells or genetic manipulation, create concerns regarding ethics in the Cell Isolation Market. These ethical considerations raise public awareness and lower consumer acceptance and influence regulatory laws, thereby limiting research activity and commercial uses in some places.

Market Competition and Innovation Pressure:

The Cell Isolation Market is competitive, with many competitors competing to provide innovative solutions. Keeping up with rapid technological improvements and addressing the changing needs of end users while controlling costs demands significant investment and presents a substantial challenge for preserving profitability and market position.

Key Trends:

Automation and High-throughput Technologies:

There is an increasing trend of automating cell isolation methods in order to boost throughput, eliminate manual errors, and improve reproducibility. Automated methods and equipment capable of processing several samples at the same time with minimal human interaction are gaining popularity and further stimulating market expansion.

Growth in Stem Cell Research and Therapy:

The expanding field of stem cell research, as well as the increased use of stem cells in therapeutic therapies, are driving demand for efficient cell isolation techniques. Isolating high-quality stem cells has become essential for regenerative medicine, tissue engineering, and diverse cell therapies, which is driving advancements in gentle and efficient isolation technologies that preserve cell integrity and activity.

Advanced Techniques for Specific Cell Isolation:

FACS and MACS techniques are advancing, resulting in improved purity and viability of separated cells. The development of microfluidics-based cell isolation technologies is also on the rise, enabling the exact identification of certain cell types, even from heterogeneous samples, which is vital to research, therapy, and diagnostics.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Cell Isolation Market Regional Analysis

Here is a more detailed regional analysis of the Cell Isolation Market:

North America:

According to Verified Market Research, North America is estimated to dominate the Cell Isolation Market over the forecast period. The region has experienced significant financial investment in the healthcare and biotechnology industries, especially cell-based research and medicines. These investments enable the creation and commercialization of cutting-edge cell separation technologies and services, resulting in market growth.

North America is a pioneer in the field of personalized medicine, which is mainly reliant on cell-based therapies and diagnoses. The demand for personalized treatments, such as stem cell therapies and immunotherapies, necessitates precise cell isolation and analysis, driving the market for cell isolation technologies.

Furthermore, North America's regulatory environment, particularly in the United States through the FDA (FDA), fosters innovation in the biotechnology and pharmaceutical sectors. The regulatory processes for cell-based medicines and goods are well established, allowing for faster approval and acceptance of innovative technology. This favorable regulatory framework encourages companies to develop and promote new cell isolation technologies and products.

Europe:

Europe has well-established healthcare systems and significant healthcare spending, thereby offering easy accessibility to modern medical technology, such as cell isolation. This infrastructure enables continued medical research and the deployment of innovative therapeutics, resulting in consistent growth in the market.

Europe's ageing population and rising chronic illness burden demand cutting-edge diagnostic and therapeutic techniques, including cell-based medicines. The requirement for precise cell separation in research and clinical applications is fueling market expansion.

Furthermore, the European Union provides comprehensive regulatory frameworks and financing systems for biomedical research, promoting innovation in cell isolation technology. Horizon Europe, for instance, encourages research cooperation while also advancing technology and expanding the market.

Asia Pacific:

Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Asia-Pacific's biotechnology companies are booming, owing to increased investment and support offered by the government authorities. This expansion is generating demand for cell separation technologies, which are critical for research and development, biopharmaceutical production, and clinical diagnostics.

The region's healthcare infrastructure is rapidly expanding, with both governments and the private sector investing in hospitals and research organizations. This expansion promotes the use of modern technologies such as cell isolation for medicinal and diagnostic purposes.

Furthermore, Asia Pacific faces an increasing burden of chronic diseases such as cancer and diabetes, necessitating new diagnostic and therapeutic approaches. As a result, cell isolation is becoming essential for further application in personalized medicine and tailored therapeutics, driving market growth.

Cell Isolation Market: Segmentation Analysis

The Cell Isolation Market is Segmented based on Product, Cell Type, Cell Source, End User, and Geography.

Cell Isolation Market, By Product

• Consumables
• Reagents, Kits, Media & Sera
• Beads
• Disposables
• Instruments
• Centrifuges
• Cell Sorters
• Magnetic-activated Cell Separator Systems
• Filtration Systems

Based on Product, the market is segmented into Consumables and Instruments. The consumables segment is estimated to dominate the Cell Isolation Market. Consumables such as reagents, kits, medium, sera, beads, and disposables have vital and recurring requirements in cell isolation techniques, necessitating repeated purchases. These materials are essential for both basic research and clinical applications, resulting in significant demand from a diverse spectrum of end users, including research laboratories, biotechnology and pharmaceutical businesses, and healthcare providers. Furthermore, the introduction of specialized consumables that improve the efficiency and specificity of cell isolation techniques has accelerated their adoption.

Cell Isolation Market, By Cell Type

• Human Cells
• Animal Cells

Based on Cell Type, the market is segmented into Human Cells and Animal Cells. The human cells segment is estimated to dominate the Cell Isolation Market during the forecast period due to the widespread use of human cells in a variety of applications, such as biomedical research, regenerative medicine, cancer research, and cell-based therapeutics. The increased emphasis on personalized medicine, which frequently uses human cell models to investigate disease causes and evaluate therapeutic therapies, fuels the demand for human cell isolation. Furthermore, increased investment in stem cell research and the rising prevalence of chronic diseases is surging the application of cell-based treatments, leading to greater demand for human cells than animal cells.

Cell Isolation Market, By Cell Source

• Bone Marrow
• Adipose Tissues
• Cord Blood/Embryonic Stem Cells
• Other Cell Sources

Based on Cell Source, the market is segmented into Bone Marrow, Adipose Tissues, Cord Blood/ Embryonic Stem Cells, and Other Cell Sources. The bone marrow segment is estimated to exhibit the highest growth within the Cell Isolation Market due to the crucial function of bone marrow-derived cells in a variety of therapeutic applications, such as regenerative medicine, hematopoietic stem cell transplantation, and immune system reconstitution. Bone marrow cells are the primary source of mesenchymal stem cells (MSCs) and hematopoietic stem cells (HSCs), which are required to cure a variety of hematological illnesses, restore bone and cartilage, and conduct research and development on new medicines.

Cell Isolation Market, By End User

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Hospitals & Diagnostic Laboratories
• Other End Users

Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Laboratories, and Other End Users. The pharmaceutical & biotechnology companies segment is estimated to dominate the Cell Isolation Market due to these businesses' significant spending in research and development (R&D) efforts, particularly in the creation of innovative medicines, vaccines, and diagnostics that necessitate high-purity cell isolates for efficacy and safety tests. Furthermore, the push for personalized medicine and sophisticated medicines, such as cell and gene therapies, has increased the demand for accurate cell isolation technology.

Key Players

• The "Global Cell Isolation Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Thermo Fisher Scientific, Miltenyi Biotec, BD Biosciences, Merck, Eppendorf, GE Healthcare, Danaher Corporation, PerkinElmer, Agilent Technologies, Bio-Rad Laboratories, Takara Bio, Sigma-Aldrich, Promega Corporation, Lonza, Cell Signaling Technology, STEMCELL Technologies, Miltenyi Biotec, Apogee Flow Systems, and Fluidigm Corporation.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In February 2024, Miltenyi Biotec introduced a new microfluidic platform for high-throughput cell isolation. This approach offers faster and more efficient separation of rare cell populations, which could aid fields such as cancer research and personalized treatment.
• In February 2024, BD Biosciences and Roche collaborated to develop a new cancer cell therapy. This cooperation combines BD's cell isolation capabilities with Roche's immunotherapies to develop more effective cancer treatments.
• In February 2024, Eppendorf acquired a cell manipulation company, expanding its cell isolation portfolio. This acquisition increases Eppendorf's position in the cell separation sector, providing researchers with a broader choice of tools and technology.
• In February 2024, Agilent Technologies partnered with academic institutions to develop novel cell isolation techniques. This collaboration intends to boost cell isolation research, which could lead to breakthroughs.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CELL ISOLATION MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL CELL ISOLATION MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL CELL ISOLATION MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Consumables
  • 5.2.1 Reagents, Kits, Media & Sera
  • 5.2.2 Beads
  • 5.2.3 Disposables
• 5.3 Instruments
  • 5.3.1 Centrifuges
  • 5.3.2 Cell Sorters
  • 5.3.3 Magnetic-activated Cell Separator Systems
  • 5.3.4 Filtration Systems

6 GLOBAL CELL ISOLATION MARKET, BY CELL-TYPE

• 6.1 Overview
• 6.2 Human Cells
• 6.3 Animal Cells

7 GLOBAL CELL ISOLATION MARKET, BY CELL SOURCE

• 7.1 Overview
• 7.2 Bone Marrow
• 7.3 Adipose Tissues
• 7.4 Cord Blood/Embryonic Stem Cells
• 7.5 Other Cell Sources

8 GLOBAL CELL ISOLATION MARKET, BY END USER

• 8.1 Overview
• 8.2 Pharmaceutical & Biotechnology Companies
• 8.3 Academic & Research Institutes
• 8.4 Hospitals & Diagnostic Laboratories
• 8.5 Other End Users

9 GLOBAL CELL ISOLATION MARKET, BY GEOGRAPHY

• 9.1 Overview
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 U.K.
  • 9.3.3 France
  • 9.3.4 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Rest of Asia Pacific
• 9.5 Rest of the World
  • 9.5.1 Latin America
  • 9.5.2 Middle East & Africa

10 GLOBAL CELL ISOLATION MARKET COMPETITIVE LANDSCAPE

• 10.1 Overview
• 10.2 Company Market Ranking
• 10.3 Key Development Strategies

11 COMPANY PROFILES

• 11.1 Thermo Fisher Scientific
  • 11.1.1 Overview
  • 11.1.2 Financial Performance
  • 11.1.3 Product Outlook
  • 11.1.4 Key Developments
• 11.2 Miltenyi Biotec
  • 11.2.1 Overview
  • 11.2.2 Financial Performance
  • 11.2.3 Product Outlook
  • 11.2.4 Key Developments
• 11.3 BD Biosciences
  • 11.3.1 Overview
  • 11.3.2 Financial Performance
  • 11.3.3 Product Outlook
  • 11.3.4 Key Developments
• 11.4 Merck
  • 11.4.1 Overview
  • 11.4.2 Financial Performance
  • 11.4.3 Product Outlook
  • 11.4.4 Key Developments
• 11.5 Eppendorf
  • 11.5.1 Overview
  • 11.5.2 Financial Performance
  • 11.5.3 Product Outlook
  • 11.5.4 Key Developments
• 11.6 GE Healthcare
  • 11.6.1 Overview
  • 11.6.2 Financial Performance
  • 11.6.3 Product Outlook
  • 11.6.4 Key Developments
• 11.7 Danaher Corporation
  • 11.7.1 Overview
  • 11.7.2 Financial Performance
  • 11.7.3 Product Outlook
  • 11.7.4 Key Developments
• 11.8 PerkinElmer
  • 11.7.1 Overview
  • 11.7.2 Financial Performance
  • 11.7.3 Product Outlook
  • 11.7.4 Key Developments
• 11.9 Agilent Technologies
  • 11.7.1 Overview
  • 11.7.2 Financial Performance
  • 11.7.3 Product Outlook
  • 11.7.4 Key Developments
• 11.10 Bio-Rad Laboratories
  • 11.7.1 Overview
  • 11.7.2 Financial Performance
  • 11.7.3 Product Outlook
  • 11.7.4 Key Developments

12 Appendix

• 12.1 Related Research